Sonova Holding AG
SIX:SOON
Net Margin
Sonova Holding AG
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CH |
|
Sonova Holding AG
SIX:SOON
|
15.4B CHF |
14%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
231.3B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
198B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
155.7B USD |
12%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
146.2B USD |
12%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
106.4B USD |
14%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52.2B EUR |
9%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
49.5B USD |
7%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46B USD |
75%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
41.4B USD |
23%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
273.9B CNY |
31%
|
Sonova Holding AG
Glance View
In the world of audiological solutions, Sonova Holding AG stands out as a beacon of innovation and influence. Based in Switzerland, this company has carved a niche for itself as a global leader in hearing care solutions. Sonova’s operations span the entire spectrum of the hearing care market, from manufacturing hearing instruments to cochlear implants and advanced wireless communication systems. Their unique value proposition lies in the integration of cutting-edge technology with a deep understanding of consumer needs, which allows them to offer tailored solutions that enhance the lives of the hearing impaired. Through a network of brands, including Phonak and Unitron, Sonova ensures a broad reach and caters to diverse customer segments across different geographies. The strength of Sonova's offerings is underscored by continuous investment in research and development, which helps maintain a competitive edge in innovation-driven product lines. The business model of Sonova integrates design, technology, and service with a steady output of hearing solutions that meet high-quality standards. The company generates revenue primarily from the sales of hearing devices, which include both traditional hearing aids and more technologically advanced options like cochlear implants. Additionally, Sonova benefits from sales of audiological care services, leveraging a global network of audiologists and service points to provide personalized care and support. This combination of product and service sales creates a resilient revenue stream that is further bolstered by the company's strategic acquisitions and partnerships, which expand both its technological resources and its market presence. Through this combination of an expansive product portfolio and a robust service network, Sonova not only secures financial success but also contributes meaningfully to the broader community by addressing one of the most fundamental human needs—communication.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Sonova Holding AG's most recent financial statements, the company has Net Margin of 14%.
You don't have any saved screeners yet